4
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Buprenorphine dosing regime in the management of out-patient heroin withdrawal

Pages 39-45 | Published online: 12 Jul 2009

  • MelIo NK, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science 1980;207:657-9.
  • Jasinski DR, et al. Progress report of the NlDA Addiction Research Centre, Baltimore, Maryland. In: Harris LS, ed. Problems of drug dependence. NIDA research monograph series. Rockville, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1984:69-76.
  • Kosten TR, Kleber HD. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci 1988; 42:635-41.
  • Bickel WK, Stitzer ML, Bigelow GE, et al. Buprenorphine: dose related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther 1988; 247:47-53.
  • Rosen MI, et al. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend 1994;35:141-9.
  • Cheskin LJ, Fudala PJ, Johnson RE. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend 1994;36-115-21.
  • Kosten TR, Morgan C, Kleber HD. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. In: Blaine JD, ed. Buprenorphine: an alternative treatment for opioid dependence. NIDA research monograph series. Rockville, MD: US Department of Health and Human Services, 1992:101-19.
  • Umbricht A, et al. Naltrexone shortened opioid detoxification with buprenorphine. Drug Alcohol Depend 1999;56:181-90.
  • Nigam AK, Ray R, Tripathi M. Buprenorphine in opiate withdrawal: a comparison with clonidine. J Subst Abuse Treat 1993;10:391-4.
  • Schneider U, et al. Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study. Addict Biol 2000;5:65-9.
  • Liu ZM, et al. Rapid detoxification of heroin dependence by buprenorphine. Chung Kuo Yao Li Hsueh Pao 1997; 18:112-14.
  • Vignau J. Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine. Eur Addict Res 1998;4:29-31.
  • O'Connor P, et al. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Int Med 1997;! 27:526-30.
  • Diamant K, et al. Out--patient opiate detoxification treatment with buprenorphine. Eur Addict Res 1998;4: 198-202.
  • Nath RP, et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol 1999;39:619-23.
  • Handelsman L, et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13: 293-308.
  • Lintzeris N, Dunlop A, Thornton, D. Getting through heroin withdrawal: a guide for people trying to stop heroin use. Fitzroy, Victoria: Turning Feint Alcohol and Drug Centre; 1996:36.
  • Darke S, et al. Estimating drug consumption in opioid users: reliability and validity of a 'recent use' episodes method. Br J Addict 1991;86:1311-16.
  • Kosten TR, et al. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993;181:358-64.
  • Seow SS, et al. Buprenorphine: a new maintenance opiate? Med J Aust 1986;144:407-11.
  • Schottenfeld RS, et al. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 1997;54:713-20.
  • Johnson RE, et al. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend 1995;40:17-25.
  • Schottenfeld RS, et al. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioiddependent humans. Biol Psychiatry 1993;34:66-74.
  • Kosten TR, Kleber HD. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sei 1988;42: 635-41.
  • Ling W, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998;93:475-86.
  • Walsh SL, et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569-80.
  • Walsh SL, et al. Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 1995;274:361-72.
  • Clark NC, et al. A retrospective study of the use of short term methadone for heroin withdrawal. In: Australian Professional Society of Alcohol and Other Drugs, National Conference. Sydney, 1998.
  • Roethlisberger FJ, Dickson WJ. Management of the worker. Harvard: Harvard University Press, 1939.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.